Table of Contents PART 01: Executive summary • Highlights PART 02: Scope of the report • Market overview • Top-vendor offerings PART 03: Market research methodology • Research methodology • Economic indicators PART 04: Introduction • Key market highlights PART 05: Market landscape • Market overview • Market size and forecast • Five forces analysis PART 06: Market segmentation by product • Diagnostic EP devices • Treatment EP devices PART 07: Market segmentation by end-users • Hospitals • Clinics • Diagnostic centers PART 08: Geographical segmentation • EP devices market in Americas • EP devices market in EMEA • EP devices market in APAC PART 09: Market drivers • Increasing incidence of arrhythmia cases • Increasing preference for remote monitoring devices • High demand for EP devices PART 10: Impact of drivers PART 11: Market challenges • High cost of ablation procedures • Side-effects associated with X-ray systems • Complications associated with ablation procedures PART 12: Impact of drivers and challenges PART 13: Market trends • Development of leadless pacemaker • Increased adoption of multi-functional pacemakers • Use of mobile ECG monitoring systems PART 14: Vendor landscape • Competitive scenario PART 15: Key vendor analysis • Boston Scientific • GE Healthcare • Medtronic • Philips Healthcare • St. Jude Medical • Other prominent vendors PART 16: Appendix • List of abbreviations PART 17: Explore Technavio List of Exhibits Exhibit 01: Product offerings Exhibit 02: Global EP devices market 2015-2020 ($ billions) Exhibit 03: Factors impacting the market growth 2015-2020 Exhibit 04: Five forces analysis Exhibit 05: Global EP devices market 2015-2020 Exhibit 06: Global EP devices market segmentation by product Exhibit 07: Diagnostic EP devices market 2015-2020 ($billion) Exhibit 08: X-ray systems market overview Exhibit 09: X-ray systems market 2015-2020 ($ billion) Exhibit 10: Factors affecting X-ray systems market 2015-2020 Exhibit 11: Major players in the X-ray systems market Exhibit 12: ECG devices market overview Exhibit 13: ECG devices market 2015-2020 ($ billion) Exhibit 14: Factors affecting ECG devices market 2015-2020 Exhibit 15: Major players in the ECG devices market Exhibit 16: Diagnostic EP catheters market overview Exhibit 17: Global diagnostic EP catheters market 2015-2020 ($ billion) Exhibit 18: Factors affecting diagnostic EP catheters market 2015-2020 Exhibit 19: Major players in the diagnostic EP catheters market Exhibit 20: Global EMG devices market overview Exhibit 21: Global EMG devices market 2015-2020 ($ billion) Exhibit 22: Factors affecting EMG devices market 2015-2020 Exhibit 23: Major players in the EMG devices market Exhibit 24: Global EEG devices market overview Exhibit 25: Global EEG devices market 2015-2020 ($ billion) Exhibit 26: Factors affecting EEG devices market 2015-2020 Exhibit 27: Major players in EEG devices market Exhibit 28: Global treatment EP devices market 2015-2020 ($ billion) Exhibit 29: Global ICDs market overview Exhibit 30: Global ICDs devices market 2015-2020 ($ billion) Exhibit 31: Factors affecting ICD devices market 2015-2020 Exhibit 32: Major players in the ICD devices market Exhibit 33: Global cardiac pacemakers market overview Exhibit 34: Global cardiac pacemakers market 2015-2020 ($ billions) Exhibit 35: Factor affecting cardiac pacemaker market 2015-2020 Exhibit 36: Major players in the cardiac pacemakers market Exhibit 37: Global CRT devices market overview Exhibit 38: Global CRT devices market 2015-2020 ($ billions) Exhibit 39: Factor affecting CRT devices market 2015-2020 Exhibit 40: Major players in the CRT devices market Exhibit 41: Global ablation catheters market overview Exhibit 42: Global ablation catheters market 2015-2020 ($ billion) Exhibit 43: Factors affecting ablation catheters marker 2015-2020 Exhibit 44: Major players in ablation catheters market Exhibit 45: Global EP devices market by end-users 2015 Exhibit 46: Total number of diagnostic centers in the US 2008-2013 Exhibit 47: Global EP devices market by geography in 2015 and 2020 ($ billions) Exhibit 48: Global EP devices market percentage share by geography 2015 Exhibit 49: Americas: Market overview of EP devices Exhibit 50: EP devices market in Americas 2015-2020 ($ billions) Exhibit 51: Americas: Market metrics in various countries Exhibit 52: Key takeaway: EP devices market in US Exhibit 53: EMEA: Market overview of EP devices Exhibit 54: EP devices market in EMEA 2015-2020 ($ billions) Exhibit 55: EMEA: Market metrics in various countries Exhibit 56: Pacemaker implant centers in major EMEA countries 2014 and 2015 Exhibit 57: Total number of pacemakers implanted in major EMEA countries 2014 and 2015 Exhibit 58: Number of first implants and replacements for pacemaker in 2014 Exhibit 59: Number of first implants and replacements for pacemaker in 2015 Exhibit 60: CRT devices implant centers in EMEA countries 2014 and 2015 Exhibit 61: Total number of CRT devices implanted in major EMEA countries 2014 and 2015 Exhibit 62: ICDs implantation centers in major EMEA countries 2014 and 2015 Exhibit 63: Total number of ICDs implanted in major EMEA countries 2014 and 2015 Exhibit 64: Number of ablation procedures performed in major EMEA countries 2014 and 2015 Exhibit 65: Number of atrial fibrillation ablation procedures in major EMEA countries 2014 and 2015 Exhibit 66: Insurance modality in some EMEA countries 2014 Exhibit 67: Insurance modality in a few EMEA countries 2015 Exhibit 68: APAC: Market overview of EP devices Exhibit 69: EP devices market in APAC 2015-2020 ($ billions) Exhibit 70: APAC: Market metrics in various countries Exhibit 71: Factors affecting the adoption of remote monitoring devices Exhibit 72: Impact of drivers Exhibit 73: Side-effects of X-ray systems Exhibit 74: Impact of drivers and challenges Exhibit 75: Competitive structure analysis of global EP devices market 2015 Exhibit 76: Strategic success factors of companies in global EP devices market Exhibit 77: Competitive analysis of global EP devices market 2015 Exhibit 78: Market penetration of various EP device manufacturers 2015 Exhibit 79: Boston Scientific Corporation: Strength analysis Exhibit 80: Boston Scientific Corporation: Strategy assessment Exhibit 81: Boston Scientific Corporation: Opportunity assessment Exhibit 82: GE Healthcare: Strength analysis Exhibit 83: GE Healthcare: Strategy assessment Exhibit 84: GE Healthcare: Opportunity assessment Exhibit 85: Medtronic: Strength analysis Exhibit 86: Medtronic: Strategy assessment

Boston Scientific, GE Healthcare, Medtronic, Philips Healthcare, St. Jude Medical, Siemens Healthcare, LivaNova, AngioDynamics, Atrium Medical, Biosense Webster, Cook Group, Edward Lifesciences, Innovative Cardiovascular Solutions, Transverse Medical, Cardiac Science, MicroPortScientific, Welch Allyn, Vimecon, Suzuken, Spacelabs Healthcare, Cardiac Science, Imricor Medical Systems, Advanced Cardiac Therapeutics, BIOTRONIK.